
Join to view full profile
450 Brookline AveBoston, MA 02215
Phone+1 617-632-3270
Fax+1 617-632-4410
Dr. Pollard is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2003 - 2006
University of WashingtonResidency, Pediatrics, 2000 - 2003
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Certifications & Licensure
MA State Medical License 2018 - 2026
ME State Medical License 2014 - 2018
WA State Medical License 2003 - 2016
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054...Jen-Hao Wu, Francisco Bautista, Erica Brivio, Marieke Willemse, Karey Kowalski
Clinical Pharmacokinetics. 2026-09-01 - FLT3 (CD135) expression in pediatric AML is associated with distinct features and worse outcomes with sorafenib therapy.Andrew J Menssen, Amenech B Ashango, Todd A Alonzo, Robert B Gerbing, Laura Pardo
Blood Neoplasia. 2026-08-01 - AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.Jessica A Pollard, Todd A Alonzo, Robert B Gerbing, Matthew Kutny, Betsy Hirsch
Journal of Clinical Oncology. 2026-07-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









